Glycyrrhizic Acid and 18β-Glycyrrhetinic Acid Inhibit Inflammation via PI3K/Akt/GSK3β Signaling and Glucocorticoid Receptor Activation
- 14 July 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 58 (15), 8623-8629
- https://doi.org/10.1021/jf101841r
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Overcoming steroid unresponsiveness in airways diseaseBiochemical Society Transactions, 2009
- Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophagesClinical and Experimental Immunology, 2009
- Immunologic Aspects of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2009
- Glycyrrhizin attenuates the development of carrageenan-induced lung injury in micePharmacological Research, 2008
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- Glycyrrhizin alleviates experimental allergic asthma in miceInternational Immunopharmacology, 2006
- Adverse effects of topical glucocorticosteroidsJournal of the American Academy of Dermatology, 2006
- Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndromeInternational Immunopharmacology, 2005
- Glucocorticoids: Effects on Gene TranscriptionProceedings of the American Thoracic Society, 2004
- THE PHARMACOKINETICS OF GLYCYRRHIZIC ACID EVALUATED BY PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING†Drug Metabolism Reviews, 2001